炎症性肠病中的单细胞奥米克:最近的见解和未来的临床应用
Victoria Gudiño1,2, Raquel Bartolomé-Casado3,4, Azucena Salas5,2
1Inflammatory Bowel Disease Unit, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Hospital Clinic of Barcelona, Barcelona, Spain.
Gut
|February 4, 2025
概括
单细胞奥米克通过详细描述性结肠炎 (UC) 和克罗恩病 (CD) 的细胞变化,彻底改变了炎症性肠病 (IBD) 研究. 这些先进的技术可以识别新的治疗点,并预测治疗反应,以获得更好的患者结果.
科学领域:
- 胃肠病学 胃肠病学
- 免疫学 免疫学 免疫学
- 基因组学就是基因组学.
背景情况:
- 炎症性肠道疾病 (IBD),包括性结肠炎 (UC) 和克罗恩病 (CD),涉及影响多种细胞类型的复杂肠道炎症.
- 传统的批量转录学掩盖了对了解IBD病原体至关重要的细胞特异性见解.
- 单细胞奥米克技术为分析IBD细胞异质性提供了前所未有的分辨率.
研究的目的:
- 在UC和CD中提供单细胞奥米学研究的全面审查.
- 突出有关细胞类型,功能和疾病机制的关键发现.
- 讨论单细胞奥米克在IBD诊断,治疗和预后方面的临床潜力.
主要方法:
- 在IBD研究中对单细胞奥米克应用现有文献的审查.
- 分析单细胞RNA测序和其他单细胞奥米克技术的数据.
- 综合与细胞变化,疾病并发症和治疗反应相关的发现.
主要成果:
- 单细胞奥米学在健康和炎症肠道组织中发现了新的细胞类型和功能.
- 这些技术有助于了解疾病的活性,并发症 (例如纤维,) 和治疗反应.
- 新兴应用包括识别药物失效机制和开发预测生物标志物.
结论:
- 单细胞奥米克为IBD复杂性提供了深入的见解,超越了批量分析的局限性.
- 这些方法对于发现治疗点和了解UC和CD治疗变异性至关重要.
- 将其纳入临床实践有望在IBD诊断,监测和个性化医疗方面取得进展.
相关概念视频
01:30Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
306
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
306
01:27Inflammatory Bowel Disease I: Ulcerative Colitis
127
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
127
01:30Inflammatory Bowel Disease II: Crohn's Disease
172
Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
172
01:29Inflammatory Bowel Disease IV: Pharmacological Management
100
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
100